ExploreWatchlistsPricing
  1. US-listed companies
  2. BRAINSTORM CELL THERAPEUTICS INC.
  3. Financials
  4. Cash from investing

BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Market cap
$11.03M
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 20240-99.45%
Dec 31, 20232+119.74%
Dec 31, 20221+208.98%
Dec 31, 20210-107.26%
Dec 31, 2020-4-179.27%
Dec 31, 20196-561.08%
Dec 31, 2018-1-130.56%
Dec 31, 20174-33.31%
Dec 31, 20166-152.97%
Dec 31, 2015-11+153.55%
Dec 31, 2014-4-267.55%
Dec 31, 20133-192.90%
Dec 31, 2012-3+4367.19%
Dec 31, 2011-0

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat